Proskauer and Kirkland & Ellis secured a decisive victory for Gilead Sciences, Inc. in a $3.6 billion antitrust case on allegations that the pharmaceutical company struck…
Gilead Sciences’ $3.6 Billion HIV Drug Antitrust Case


Proskauer and Kirkland & Ellis secured a decisive victory for Gilead Sciences, Inc. in a $3.6 billion antitrust case on allegations that the pharmaceutical company struck…
…